Type 2 Diabetes Patients Weary Of Byetta
Byetta (exenatide) is a type 2 diabetes treatment that controls glucose, or blood sugar, levels in individuals who are non-insulin dependent. The injectable drug, manufactured by Amylin Pharmaceuticals and Eli Lilly, was approved for market use in 2005. Read more
Welchol Lowers A1C In Diabetes Patients
Data from Daiichi Sankyo’s post-hoc analyses of three pivotal studies demonstrated that the addition of Welchol, (colesevelam HCl) to common diabetes treatment regimens can lower A1C in patients with type 2 diabetes mellitus by 1% or greater. Read more
Pine Bark Reduces Cardiovascular Risk In Diabetics
Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, reduces blood sugar in type II diabetes patients, allows people to lower their antihypertensive medication and improves cardiovascular disease (CVD) risk factors. Read more